Eyal Rubin
Overview
Eyal Rubin received an average of $800K in total compensation, including $262K in salary, at Protalix BioTherapeutics from 2019 to 2023.
2023Protalix BioTherapeuticsSenior Vice President and Chief Financial Officer
2022Protalix BioTherapeuticsSenior Vice President, Chief Financial Officer
2021Protalix BioTherapeuticsSenior Vice President, Chief Financial Officer
2020Protalix BioTherapeuticsSenior Vice President, Chief Financial Officer
2019Protalix BioTherapeuticsSenior Vice President, Chief Financial Officer
Source: SEC filings on April 29, 2024, May 18, 2023, April 29, 2022, and April 15, 2020.
Related executives
We found ten more executives who work or worked at Protalix BioTherapeutics.
Dror Bashan
Protalix BioTherapeutics
Chief Executive Officer
Yaron Naos
Protalix BioTherapeutics
Senior Vice President, Operations
Einat Almon
Protalix BioTherapeutics
Senior Vice President, Chief Development Officer
Moshe Manor
Protalix BioTherapeutics
Chief Executive Officer
Yoseph Shaaltiel
Protalix BioTherapeutics
Executive Vice President, Research and Development
Yossi Maimon
Protalix BioTherapeutics
Chief Financial Officer
Tzvi Palash
Protalix BioTherapeutics
Chief Operating Officer
David Aviezer
Protalix BioTherapeutics
Chief Executive Officer
News
Protalix BioTherapeutics CEO Dror Bashan's 2023 pay jumps 83% to $2.7M
April 29, 2024
Protalix BioTherapeutics CEO Dror Bashan's 2022 pay jumps 27% to $1.5M
May 18, 2023
Protalix BioTherapeutics CEO Dror Bashan's 2021 pay slips 14% to $1.2M
April 29, 2022
Protalix BioTherapeutics CEO Moshe Manor's 2019 pay slips 14% to $616K
April 15, 2020